CER METHODS SERIES: Alternatives to the Conventional RCT | Michael Kosorok, PhD & Peter Thall, PhD
Date/Time
Date(s) - 09/13/2013
8:00 am - 10:00 am
Location
The Carolina Club, George Watts Hill Alumni Center
Category(ies)
Comparative Effectiveness Research Methods Series: Applications to Health Services Research: Alternatives to the Conventional RCT
Michael Kosorok, Ph.D., Professor & Chairman, Department of Biostatistics
Peter Thall, Ph.D., Professor, Biostatistics, The University of Texas MD Anderson Cancer Center
Location: Carolina Club, Alumni Hall I (Breakfast will be provided)
Background Reading Information
1. Biometrics. 2011 Dec;67(4):1422-33. doi: 10.1111/j.1541-0420.2011.01572.x. Epub 2011 Mar 8.
Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer.
Zhao Y, Zeng D, Socinski MA, Kosorok MR.
2. Blood. 2003 Jul 15;102(2):442-8. Epub 2003 Jan 30.
New designs for phase 2 clinical trials.
Estey EH, Thall PF.
3. Eur J Cancer. 2007 Mar;43(5):859-66. Epub 2007 Feb 16.
Practical Bayesian adaptive randomisation in clinical trials.
Thall PF, Wathen JK.
4. Curr Opin Oncol. 2008 Jul;20(4):407-11. doi: 10.1097/CCO.0b013e328302163c.
Bayesian designs to account for patient heterogeneity in phase II clinical trials.
Thall PF, Wathen JK.
5. The University of North Carolina at Chapel Hill Department of Biostatistics Technical Report Series. Working Paper 25.
Research Methods for Clinical Trials in Personalized Medicine: A Systematic Review.
Ren S, Davidian M, George SL, Goldberg RM, Wright FA, Tsiatis AA, Kosorok MR.